Saturday Edition
Stay updated with Archyde – your source for breaking news, global headlines, economy, entertainment, health, technology, and sports. Fresh stories daily.
As of this week, the global weight loss medication landscape has shifted with the FDA’s accelerated approval of retatrutide—a novel triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors—marking the first ... Read More
Continuous Coverage
The moment the U.S. Coast Guard boarding team stormed the MV Medea in the Gulf of Oman last…
WHO Expands Access to Fast-Acting Insulin and Semaglutide Amid Global Diabetes and Obesity Crisis Following Tuesday’s regulatory announcement,…
South Korean winger Hwang Hee-chan is set for a dramatic exit from Wolverhampton after their Premier League relegation,…
As of May 15, 2026, a Manhattan judge has declared a mistrial in Harvey Weinstein’s third New York…
Nvidia (NASDAQ: NVDA) continues to command market attention as Raymond James maintains its bullish stance, citing robust artificial…
Ukrainian President Volodymyr Zelenskyy has warned of imminent Russian strikes on his presidential residence in Kyiv and dozens…
Global Affairs
Canada’s sudden embrace of Eurovisión—Europe’s most beloved cultural export—marks a quiet but seismic shift in transatlantic soft power…
Markets And Money
The Geely Automobile Holdings (HKG: 0175) E2, a sub-compact electric vehicle unveiled at Auto China 2026, signals a…
Digital Culture
Marathon’s PVE-Only Mode: A Technical Deep Dive into Server-Side AI and Multiplayer Architecture Marathon’s second season introduces a…
Science And Wellbeing
Why Vaccine Prices Vary Across Dutch GGD Clinics: A Public Health Analysis Across the Netherlands, vaccine costs differ…
Screen And Sound
Marina Collins, Archyde’s Entertainment Editor, breaks down the Lune Rousse Festival’s 2026 lineup, revealing how a Breton cultural…
Fixtures And Form
Ajax winger Mika Godts has been excluded from Belgium’s 2026 World Cup squad, a decision that underscores the…
